Headquarters
6555 CARNEGIE AVE FL 4, CLEVELAND, OH 44103-4637, US
CLEVELAND, OH, US
From the company
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing and delivering cell and gene therapies for serious diseases with high unmet need. Its ZEVASKYN (prademagene zamikeracel) was approved in April 2025, and its fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. Its development portfolio features PSMA-SIR-T, an engineered T-cell therapy targeting Prostate-Specific Membrane Antigen.
6555 CARNEGIE AVE FL 4, CLEVELAND, OH 44103-4637, US
Quantities, certifications, and timing.